Chinese General Practice ›› 2023, Vol. 26 ›› Issue (27): 3430-3434.DOI: 10.12114/j.issn.1007-9572.2023.0081
• Article • Previous Articles Next Articles
Received:
2023-01-31
Revised:
2023-03-11
Published:
2023-09-20
Online:
2023-03-23
Contact:
LIN Jia
通讯作者:
林佳
作者简介:
基金资助:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2023.0081
组别 | 例数 | 性别(男/女) | 年龄(岁) | 高血压〔例(%)〕 | 糖尿病〔例(%)〕 | 高脂血症〔例(%)〕 | 吸烟史〔例(%)〕 | HGB (g/L) | PLT (×109/L) | CRP (mg/L) | ALB (g/L) |
---|---|---|---|---|---|---|---|---|---|---|---|
CCC形成良好组 | 52 | 36/16 | 64.5±6.8 | 38(73.1) | 13(25.0) | 30(57.7) | 15(28.8) | 135.36±13.79 | 183.36±49.98 | 6.86±4.08 | 45.95±3.85 |
CCC形成不良组 | 83 | 51/32 | 66.0±7.3 | 53(63.9) | 40(48.2) | 45(54.2) | 39(47.0) | 133.42±13.55 | 193.48±52.26 | 11.84±5.26 | 41.53±5.10 |
检验统计量值 | 0.85a | -0.98 | 1.24a | 7.21a | 0.16a | 4.38a | 0.80 | -1.11 | -5.82 | 5.36 | |
P值 | 0.358 | 0.330 | 0.266 | 0.007 | 0.692 | 0.036 | 0.420 | 0.270 | <0.001 | <0.001 | |
组别 | FBG (mmol/L) | TG (mmol/L) | TC (mmol/L) | LDL-C (mmol/L) | HDL-C (mmol/L) | UA (μmol/L) | Scr (μmol/L) | BUN (mmol/L) | CAR 〔M(P25,P75),%〕 | ||
CCC形成良好组 | 6.13±1.82 | 1.67±0.81 | 4.50±1.14 | 2.33±0.82 | 1.01±0.34 | 388.66±109.39 | 80.42±16.70 | 5.75±1.52 | 14.53(7.03,20.66) | ||
CCC形成不良组 | 6.29±2.06 | 1.95±1.09 | 4.39±1.33 | 2.61±0.89 | 0.97±0.35 | 377.15±98.98 | 80.94±20.44 | 5.67±1.74 | 27.54(19.44,35.21) | ||
检验统计量值 | -0.48 | -1.59 | 0.50 | -1.86 | 0.68 | 0.63 | -0.16 | 0.25 | -6.10b | ||
P值 | 0.630 | 0.120 | 0.620 | 0.065 | 0.490 | 0.530 | 0.880 | 0.800 | <0.001 |
Table 1 Comparison of clinical data between two groups
组别 | 例数 | 性别(男/女) | 年龄(岁) | 高血压〔例(%)〕 | 糖尿病〔例(%)〕 | 高脂血症〔例(%)〕 | 吸烟史〔例(%)〕 | HGB (g/L) | PLT (×109/L) | CRP (mg/L) | ALB (g/L) |
---|---|---|---|---|---|---|---|---|---|---|---|
CCC形成良好组 | 52 | 36/16 | 64.5±6.8 | 38(73.1) | 13(25.0) | 30(57.7) | 15(28.8) | 135.36±13.79 | 183.36±49.98 | 6.86±4.08 | 45.95±3.85 |
CCC形成不良组 | 83 | 51/32 | 66.0±7.3 | 53(63.9) | 40(48.2) | 45(54.2) | 39(47.0) | 133.42±13.55 | 193.48±52.26 | 11.84±5.26 | 41.53±5.10 |
检验统计量值 | 0.85a | -0.98 | 1.24a | 7.21a | 0.16a | 4.38a | 0.80 | -1.11 | -5.82 | 5.36 | |
P值 | 0.358 | 0.330 | 0.266 | 0.007 | 0.692 | 0.036 | 0.420 | 0.270 | <0.001 | <0.001 | |
组别 | FBG (mmol/L) | TG (mmol/L) | TC (mmol/L) | LDL-C (mmol/L) | HDL-C (mmol/L) | UA (μmol/L) | Scr (μmol/L) | BUN (mmol/L) | CAR 〔M(P25,P75),%〕 | ||
CCC形成良好组 | 6.13±1.82 | 1.67±0.81 | 4.50±1.14 | 2.33±0.82 | 1.01±0.34 | 388.66±109.39 | 80.42±16.70 | 5.75±1.52 | 14.53(7.03,20.66) | ||
CCC形成不良组 | 6.29±2.06 | 1.95±1.09 | 4.39±1.33 | 2.61±0.89 | 0.97±0.35 | 377.15±98.98 | 80.94±20.44 | 5.67±1.74 | 27.54(19.44,35.21) | ||
检验统计量值 | -0.48 | -1.59 | 0.50 | -1.86 | 0.68 | 0.63 | -0.16 | 0.25 | -6.10b | ||
P值 | 0.630 | 0.120 | 0.620 | 0.065 | 0.490 | 0.530 | 0.880 | 0.800 | <0.001 |
自变量 | 单因素Logistic回归分析 | 多因素Logistic回归分析 | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
B | SE | Wald χ2值 | OR(95%CI) | P值 | B | SE | Wald χ2值 | OR(95%CI) | P值 | |
糖尿病 | 1.026 | 1.084 | 7.43 | 2.791(1.304,5.974) | 0.008 | 0.959 | 1.215 | 50.47 | 2.609(1.048,6.450) | 0.039 |
吸烟史 | 0.782 | 0.824 | 4.47 | 2.186(1.044,4.577) | 0.038 | 0.760 | 0.999 | 50.47 | 2.139(0.856,5.344) | 0.104 |
CRP | 0.234 | 0.063 | 32.06 | 1.264(1.146,1.393) | <0.001 | |||||
ALB | -0.214 | 0.039 | 26.92 | 0.808(0.735,0.887) | <0.001 | |||||
TG | 0.291 | 0.248 | 2.55 | 1.338(0.930,1.925) | 0.117 | |||||
LDL-C | 0.389 | 0.314 | 3.49 | 1.476(0.973,2.240) | 0.067 | |||||
CAR | 0.120 | 0.027 | 42.23 | 1.128(1.077,1.181) | <0.001 | 0.125 | 0.029 | 50.47 | 1.134(1.078,1.192) | <0.001 |
Table 2 The results of univariate and multivariate Logistic regression analyses of influencing factors of poor-developed CCC in UAP patients
自变量 | 单因素Logistic回归分析 | 多因素Logistic回归分析 | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
B | SE | Wald χ2值 | OR(95%CI) | P值 | B | SE | Wald χ2值 | OR(95%CI) | P值 | |
糖尿病 | 1.026 | 1.084 | 7.43 | 2.791(1.304,5.974) | 0.008 | 0.959 | 1.215 | 50.47 | 2.609(1.048,6.450) | 0.039 |
吸烟史 | 0.782 | 0.824 | 4.47 | 2.186(1.044,4.577) | 0.038 | 0.760 | 0.999 | 50.47 | 2.139(0.856,5.344) | 0.104 |
CRP | 0.234 | 0.063 | 32.06 | 1.264(1.146,1.393) | <0.001 | |||||
ALB | -0.214 | 0.039 | 26.92 | 0.808(0.735,0.887) | <0.001 | |||||
TG | 0.291 | 0.248 | 2.55 | 1.338(0.930,1.925) | 0.117 | |||||
LDL-C | 0.389 | 0.314 | 3.49 | 1.476(0.973,2.240) | 0.067 | |||||
CAR | 0.120 | 0.027 | 42.23 | 1.128(1.077,1.181) | <0.001 | 0.125 | 0.029 | 50.47 | 1.134(1.078,1.192) | <0.001 |
指标 | 最佳截断值 | 灵敏度 | 特异度 | AUC(95%CI) | P值 |
---|---|---|---|---|---|
CRP | 8.42 mg/L | 0.735 | 0.712 | 0.771(0.691,0.851) | <0.01 |
ALB | 43.63 g/L | 0.651 | 0.769 | 0.745(0.663,0.827) | <0.01 |
CAR | 17.42% | 0.855 | 0.692 | 0.813(0.739,0.886) | <0.01 |
Table 3 Related indicators of CRP,ALB and CAR in predicting poor-developed CCC in UAP patients
指标 | 最佳截断值 | 灵敏度 | 特异度 | AUC(95%CI) | P值 |
---|---|---|---|---|---|
CRP | 8.42 mg/L | 0.735 | 0.712 | 0.771(0.691,0.851) | <0.01 |
ALB | 43.63 g/L | 0.651 | 0.769 | 0.745(0.663,0.827) | <0.01 |
CAR | 17.42% | 0.855 | 0.692 | 0.813(0.739,0.886) | <0.01 |
[1] |
|
[2] |
|
[3] |
|
[4] |
|
[5] |
|
[6] |
|
[7] |
|
[8] |
|
[9] |
|
[10] |
中华医学会心血管病学分会,中华心血管病杂志编辑委员会. 不稳定性心绞痛和非ST段抬高心肌梗死诊断与治疗指南[J]. 中华心血管病杂志,2007,35(4):295-304. DOI:10.3760/j.issn:0253-3758.2007.04.003.
|
[11] |
|
[12] |
|
[13] |
崔晓伟,谷国强. 冠状动脉侧支循环影响因素及评价方法的研究进展[J]. 心血管病学进展,2021,42(5):437-441. DOI:10.16806/j.cnki.issn.1004-3934.2021.05.013.
|
[14] |
|
[15] |
|
[16] |
|
[17] |
|
[18] |
|
[19] |
|
[20] |
|
[21] |
|
[22] |
|
[23] |
|
[24] |
|
[25] |
|
[26] |
|
[1] | BAI Haiwei, MI Xiaokun, LIU Qingrui, ZHU Lin, WANG Yingnan, LIU Junyan, HAN Ying. Predictive Value of Serum Uric Acid in Perioperative Acute Ischemic Stroke in Patients with Non-small Cell Lung Cancer [J]. Chinese General Practice, 2023, 26(36): 4545-4551. |
[2] | CHU Xiaojing, LI Jun, FU Yanqin, LIU Danqing, LIU Aiping, ZHANG Yuanyuan. Effect of Human Body Composition and Serum Biochemical Indicators on the Accuracy of Flash Glucose Monitoring System [J]. Chinese General Practice, 2023, 26(35): 4433-4438. |
[3] | LUO Weigang, YIN Yuanyuan, LIU Wanhu, XU Yuzhu, CAO Xiaoyun, BU Wei, ZHANG Lingyan, REN Huiling. Correlation of Triglyceride Glucose Index with Early Neurological Deterioration in Patients with Single Subcortical Infarction [J]. Chinese General Practice, 2023, 26(35): 4419-4424. |
[4] | XIE Xuemei, GAO Jing, BAI Dingxi, LU Xianying, HE Jiali, LI Yue. Current Status of Polypharmacy in the Elderly and Its Influencing Factors: a Meta-analysis [J]. Chinese General Practice, 2023, 26(35): 4394-4403. |
[5] | WANG Yue, CHEN Qing, LIU Lurong. Detection Rate of Depression and Its Influencing Factors in Chinese Elderly: a Meta-analysis [J]. Chinese General Practice, 2023, 26(34): 4329-4335. |
[6] | LI Dianjiang, PAN Enchun, SUN Zhongming, WEN Jinbo, WANG Miaomiao, WU Ming, SHEN Chong. The Current Status and Influencing Factors of Clinical Inertia in Type 2 Diabetes Patients in Community [J]. Chinese General Practice, 2023, 26(34): 4296-4301. |
[7] | HAO Aihua, ZENG Weilin, LI Guanhai, XIA Yinghua, CHEN Liang. Current Situation of the Construction of Family Doctor Team: an Investigation Based on the Perspective of General Practitioners [J]. Chinese General Practice, 2023, 26(34): 4261-4268. |
[8] | QIN Fengyin, ZHANG Qishan, LAI Jinjia, HUANG Yimin, HAN Guoyin, SUN Xinglan, WANG Fen, TAN Yibing. Current Status and Influencing Factors of the Intention to Screen for High-risk Stroke among Community Residents in Guangdong [J]. Chinese General Practice, 2023, 26(34): 4283-4289. |
[9] | WANG Lina, GAO Pengfei, CAO Fan, GE Ying, YAN Wei, HE Daikun. Analysis of the Prevalence and Influencing Factors of Non-alcoholic Fatty Liver Disease in Different Gender Groups [J]. Chinese General Practice, 2023, 26(33): 4143-4151. |
[10] | ZHOU Yuyu, GAO Chuan, CUI Puan, WANG Yaping, HE Zhong. Influencing Factors of Shared Decision Making between Doctors and Patients in Menopausal Hormone Therapy in Patients with Menopausal Syndrome [J]. Chinese General Practice, 2023, 26(33): 4181-4186. |
[11] | ZHANG Jin, DING Zhiguo, QI Shuo, LI Ying, LI Weiqiang, ZHANG Yuanyuan, ZHOU Tong. Relationship between Serum Thyroid Hormone Levels and Prognosis during Hospitalization in Heart Failure Patients [J]. Chinese General Practice, 2023, 26(33): 4125-4129. |
[12] | LI Qianqian, CHEN Xunrui, ZHANG Wenying, YUAN Haihua, ZHANG Yanjie, JIANG Bin, LIU Feng. Demand and Influencing Factors for Community Health Services during Chemotherapy of Patients with Advanced Cancer [J]. Chinese General Practice, 2023, 26(33): 4173-4180. |
[13] | LIANG Xuan, NA Feiyang, QIN Mengyao, YANG Hui, GUO Li, GUO Qi, REN Lei, CHEN De, LIU Donghai, ZHANG Rongfang. Clinical Characteristics and Influencing Factors of Bronchial Asthma Combined with Obstructive Sleep Apnea-hypopnea Syndrome in Children [J]. Chinese General Practice, 2023, 26(33): 4225-4230. |
[14] | GAO Dekang, WEI Shaohua, MA Xiaoming, DU Peng, XING Chungen, CAO Chun. Risk Factors for Loss of Skeletal Muscle Mass and Its Correlation with Complications after Major Hepatectomy for Liver Cancer [J]. Chinese General Practice, 2023, 26(32): 4031-4037. |
[15] | WANG Minghuan, LI Yuhong, YU Min, WANG Yougang, YU Qiaozhi, YANG Fangfang, YUAN Dehui, ZHANG Liu. Effect of Allostatic Load on Adverse Pregnancy Outcomes of Women in Late Pregnancy [J]. Chinese General Practice, 2023, 26(32): 4064-4069. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||